Researchers at R&D Center Target Alzheimer Disease (Cerebrospinal fluid from Alzheimer's disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer's disease)

MLA

“Researchers at R&D Center Target Alzheimer Disease (Cerebrospinal Fluid from Alzheimer’s Disease Patients as an Optimal Formulation for Therapeutic Application of Mesenchymal Stem Cells in Alzheimer’s Disease).” Stem Cell Week, Mar. 2020, p. 5846. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.618250886&authtype=sso&custid=ns315887.

APA

Researchers at R&D Center Target Alzheimer Disease (Cerebrospinal fluid from Alzheimer’s disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer’s disease). (2020, March 23). Stem Cell Week, 5846.

Chicago

Stem Cell Week. 2020. “Researchers at R&D Center Target Alzheimer Disease (Cerebrospinal Fluid from Alzheimer’s Disease Patients as an Optimal Formulation for Therapeutic Application of Mesenchymal Stem Cells in Alzheimer’s Disease),” March 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.618250886&authtype=sso&custid=ns315887.